Gilead Sciences Inc.
81.24-0.55 (-0.67%)

After hours: 81.22-0.02 (-0.02%) as of 4:02 PM EDT

Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close81.79
Bid81.34 x 700
Ask81.35 x 1100
52wk Range77.92 - 120.37
Day's Range80.62 - 81.98
Avg Vol (3m)10,254,663
As of 4:00 PM EDT. Market closed.
  • Forbes50 minutes ago

    What Are Analysts Saying About Q2 at Biotech's Big 4? Amgen, Biogen, Celgene, Gilead

    Second-quarter earnings season has been going for more than a week, and we’ve had a chance to hear from all four of the biggest companies in biotech as measured by sales, market valuation and clout. Here’s what they had to say in their business updates, along with some commentary from analysts

  • Reuters2 hours ago

    U.S. biotech stocks win back investors in big July run

    Biotech returned to the good graces of investors this month and it may be the beginning of a revival for stocks in the industry. With one full trading day left in the month, the Nasdaq Biotechnology index has climbed 11 percent in July, on pace for its biggest monthly percentage gain in three years. Investors have sensed an opportunity to scoop up the stocks, analysts said.